Gensight Biologics S.a annual asset turnover
2021
2022
2023
2024
2025
Gensight Biologics S.a Asset Turnover Growth & History (SIGHT)
Gensight Biologics S.a's asset turnover was 0.00 for fiscal 2025.
View full Gensight Biologics S.a company overviewGensight Biologics S.a annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | −0.15 | −99.93% |
| 2024 | 2024-12-31 | 0.15 | 0.08 | +108.78% |
| 2023 | 2023-12-31 | 0.07 | 0.01 | +15.55% |
| 2022 | 2022-12-31 | 0.06 | −0.04 | −38.37% |
| 2021 | 2021-12-31 | 0.10 | — | — |
Gensight Biologics S.a asset turnover trends
Between the periods ended 2021-12-31 and 2025-12-31, Gensight Biologics S.a's asset turnover decreased from 0.10 to 0.00, a change of −0.10.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gensight Biologics S.a source filings ↗Community posts
GenSight advances LUMEVOQ manufacturing transfer to Catalent
GenSight ($SIGHT) said an engineering batch of GS010/LUMEVOQ at Catalent was produced as planned, with viral genome concentration meeting target specifications. Preparations have begun for a GMP-standard batch to supply special-access progr ...